1.
化疗对NSCLC患者血红蛋白的影响(g/L, Mean±SD)
The impact of chemotherapy on hemoglobin in NSCLC patients (g/L, Mean±SD)
| Group | n | Before chemotherapy | After 2 cycles of chemotherapy | After 4 cycles of chemotherapy |
| Group A: Before and after chemotherapy without anemia; Group B: Before chemotherapy without anemia and after chemotherapy with anemia; Group C: Before and after chemotherapy with anemia; Δ: The self-comparative between before chemotherapy and after 2 cycles of chemotherapy, P < 0.005; *: The self-comparative between before chemotherapy and after 2 cycles of chemotherapy, P < 0.001; **: The self-comparative between after 2 and 4 cycles of chemotherapy, P < 0.001. | ||||
| A | 30 | 139.4±10.36 | 128.4±15.30Δ | 120.3±13.02** |
| B | 44 | 127.8±8.55 | 92.8±11.69* | 86.5±14.71** |
| C | 66 | 99.4±7.13 | 84.2±8.79* | 79.5±8.97** |